Retatrutide Regulatory Status Retatrutide occupies a unique position because it is not yet FDA-approved: Not FDA-approved currently in Phase 3 clinical trials with Eli Lilly No prescription pathway in the US yet no Mounjaro/Wegovy equivalent for retatrutide Legal as research chemical sold in the US for in-vitro and animal research under research-use-only labeling Likely to receive FDA approval in coming years if clinical trial endpoints meet expectations WADA status currently not specifically listed, though peptide hormones generally fall under WADA categories Not DEA-scheduled no controlled substance status Unlike semaglutide and tirzepatide, retatrutide does not yet exist as a prescription drug
Journal reference: Wang, W., Volkow, N.D., Berger, N.A., Davis, P.B., Kaelber, D.C., and Xu, R
Livraison rapide dans tout le Sngal Notre boutique Eric Favre Store propose un service de livraison express dans les 14 rgions du Sngal, partir de seulement 1500 CFA
Nature 585 , 277282 (2020)
